Clinical Trial

Prevalence and Predictive Factors of Difficult Biliary Cannulation

Study acronym: PRECABIDO
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The main purpose of the study is to evaluate the prevalence of difficult biliary cannulation using endoscopic retrograde cholangiopancreatography (ERCP) according to the criteria defined by the European Society of Gastrointestinal Endoscopy (ESGE) and the American Society for Gastrointestinal Endoscopy (ASGE), as well as the predictive factors for this event in a prospective, multicenter study. Consecutive patients undergoing ERCP will be included in the study We will also assess: Evaluate the failure of biliary cannulation in our setting. Evaluate predictive factors for difficult cannulation and cannulation failure using ESGE criteria. Design an "a priori" predictive model for difficult cannulation and cannulation failure. Cost study: record of materials used.
Trial Details
NCT Number NCT06591364
Lead Sponsor University of La Laguna
Conditions Difficult Biliary Cannulation
Enrollment 600 participants
Start Date 2024-09-20
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-10-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-19